abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2010년 5월 27일

저자:
Global Business Coalition on HIV/AIDS, TB and Malaria (GBC)

Business Delivers as Front-Line Player in the Global Fight against HIV/AIDS, TB and Malaria

From an initiative that’s reaching 3.5 million people threatened by TB to a massive expansion of access to cheap anti-malaria medication in 24 African countries, businesses are doing work that is complementing the global health work of governments and international agencies…Eight companies will receive GBC's Awards for Excellence in Business Action…"Governments and non-profits can’t do it alone. The private sector needs to step up now…” said GBC President and CEO John Tedstrom...[awards given to Boehringer Ingelheim, Coca-Cola Africa Foundation, Eli Lilly, ExxonMobil, NBA, Newmont Ghana Gold, Sanofi-Aventis, Standard Chartered; GBC commended Accor, Bayer, Diageo, Heineken, Heineken International & Unilever Partnership, Lonmin, L’Oreal China, Standard Bank]